🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21480Original Research

WGCNA and machine learning identify autophagy and senescence signature genes in osteoarthritis chondrocytes

YANG Huaqun¹,Abudouainijiang·Abulimiti¹,WANG Fazheng¹,Maimaitishawutiaji·Maimaiti¹,LI Simi¹,Muhetaer·Maimaitirexiati¹

The First People's Hospital of Kashgar Region, Kashgar 844000, Xinjiang Uygur Autonomous Region, China

Read Executive PreviewQuick FAQ
WGCNA and machine learning identify autophagy and senescence signature genes in osteoarthritis chondrocytes
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1904, Issue 32 • pp. 100-112Citation:YANG Huaqun et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Identified 26 autophagy- and senescence-related differentially expressed genes in osteoarthritis via bioinformatics and machine learning. • Six key genes (UBE2I, RPS6KB1, IL2RB, YEATS4, H4C8, TLR3) were screened with AUC > 0.8, showing high diagnostic value. • Immune infiltration analysis revealed significant changes in immune cell proportions in osteoarthritic cartilage, including increased M1 macrophages and decreased M2 macrophages. • TLR3 and IL2RB were validated as potential key genes and therapeutic targets for osteoarthritis.
Sponsored Research Highlight

Abstract

BACKGROUND: Autophagy and senescence are considered important factors in the pathogenesis of osteoarthritis, but their specific regulatory mechanisms remain unclear. OBJECTIVE: To screen autophagy- and senescence-related genes in osteoarthritis through bioinformatics analysis combined with machine learning methods, providing new molecular targets for early diagnosis and treatment of osteoarthritis. METHODS: Osteoarthritis-related datasets (including GSE51588, GSE169077, and GSE114007) were downloaded from the GEO database. Differential expression analysis, weighted gene co-expression network analysis, and functional enrichment analysis were performed to screen autophagy- and senescence-related genes in osteoarthritis. LASSO regression, random forest (RF), and support vector machine (SVM) were used to further screen potential core genes, and receiver operating characteristic curve analysis was used to evaluate the diagnostic value of core genes. Based on the GSE51588 dataset, the CIBERSORT algorithm was used to analyze the proportions of immune cell types such as T cell subsets, B cells, and macrophages in osteoarthritis and healthy control knee cartilage specimens. The expression of ubiquitin-conjugating enzyme E2I, ribosomal protein S6 kinase 1, interleukin-2 receptor beta chain, YEATS protein family member 4, histone H4 variant, and Toll-like receptor 3 was detected in the external validation set GSE114007. Clinical knee cartilage specimens from 5 osteoarthritis patients and 5 healthy controls were collected, and RT-qPCR was used to detect the mRNA expression of these genes. RESULTS AND CONCLUSION: (1) A total of 26 autophagy- and senescence-related differentially expressed genes were obtained. Functional enrichment analysis showed that these genes were mainly involved in biological processes such as cellular homeostasis, immune regulation, and cell death, and played important roles in multiple signaling pathways. Six key genes were screened by machine learning: ubiquitin-conjugating enzyme E2I, ribosomal protein S6 kinase 1, interleukin-2 receptor beta chain, YEATS protein family member 4, histone H4 variant, and Toll-like receptor 3. The area under the receiver operating characteristic curve (AUC) values of these genes were all greater than 0.8, indicating high diagnostic performance. Immune infiltration analysis showed that the infiltration of plasma cells, resting CD4 memory T cells, resting NK cells, monocytes, M2 macrophages, eosinophils, and neutrophils was significantly decreased in the osteoarthritis group, while the infiltration of follicular helper T cells, gamma delta T cells, activated NK cells, M1 macrophages, and resting dendritic cells was significantly increased. (2) In the external validation set, the expression of ubiquitin-conjugating enzyme E2I, interleukin-2 receptor beta chain, and Toll-like receptor 3 was higher in the osteoarthritis group than in the healthy control group (P < 0.05), while there was no significant difference in the expression of histone H4 variant, YEATS protein family member 4, and ribosomal protein S6 kinase 1 between the two groups (P > 0.05). In clinical samples, the mRNA expression of ribosomal protein S6 kinase 1, interleukin-2 receptor beta chain, YEATS protein family member 4, histone H4 variant, and Toll-like receptor 3 was higher in the osteoarthritis group than in the healthy control group (P < 0.05), while there was no significant difference in the expression of ubiquitin-conjugating enzyme E2I mRNA between the two groups (P > 0.05). (3) These results indicate that Toll-like receptor 3 and interleukin-2 receptor beta chain can serve as key genes for autophagy and senescence in osteoarthritis chondrocytes, and may become diagnostic molecular markers and potential therapeutic targets for osteoarthritis.

1. Introduction

Osteoarthritis is a common chronic degenerative joint disease that primarily affects the elderly population. With the global aging population, the prevalence and disability rate of osteoarthritis continue to rise, making it one of the leading causes of functional impairment and reduced quality of life worldwide [1-2]. Osteoarthritis is characterized by degeneration of articular cartilage, subchondral bone sclerosis, synovial inflammation, and osteophyte formation [3], with clinical manifestations including persistent joint pain, stiffness, limited mobility, and in severe cases, disability [4-5]. The pathogenesis of osteoarthritis is not fully understood; traditionally, it was considered to be mainly caused by mechanical wear, but recent studies have found that inflammation, cellular senescence, and autophagy dysfunction also play important roles in the development and progression of osteoarthritis [6]. Therefore, in-depth exploration of the pathogenesis of osteoarthritis and identification of potential molecular markers and therapeutic targets have become research priorities to delay disease progression and improve patient prognosis.

Chondrocyte senescence plays a key role in the development and progression of osteoarthritis [7]. Cellular senescence is characterized by permanent cell cycle arrest and increased secretion of pro-inflammatory molecules. The senescence-associated secretory phenotype (SASP) refers to the various pro-inflammatory cytokines, matrix metalloproteinases, and growth factors secreted by senescent cells, which can alter the local microenvironment, promote cartilage degradation and inflammatory responses, and thereby drive the progression of osteoarthritis [8-9]. Autophagy is an intracellular self-degradation mechanism that maintains cellular homeostasis by clearing damaged organelles and proteins [10]. In osteoarthritis, autophagy plays a crucial role in maintaining articular cartilage homeostasis and repairing damaged chondrocytes [3,11]. Studies have shown that autophagy is a double-edged sword: moderate autophagy can maintain cellular homeostasis by clearing damaged organelles and abnormal proteins, while excessive activation may exacerbate pathological processes. The accumulation of senescent cells in osteoarthritis has been proven to be a key factor leading to tissue dysfunction and aggravated inflammatory responses. However, how to precisely regulate autophagy activity in pathological conditions and balance its protective clearance and potential destructive effects remains a core challenge in osteoarthritis treatment research.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
YANG Huaqun, Abudouainijiang·Abulimiti, WANG Fazheng, Maimaitishawutiaji·Maimaiti, LI Simi, Muhetaer·Maimaitirexiati (2026). WGCNA and machine learning identify autophagy and senescence signature genes in osteoarthritis chondrocytes. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21480
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the main objective of this study?

The main objective is to screen autophagy- and senescence-related genes in osteoarthritis using bioinformatics analysis combined with machine learning methods, providing new molecular targets for early diagnosis and treatment.

Which machine learning methods were used in this study?

LASSO regression, random forest (RF), and support vector machine (SVM) were used to screen potential core genes.

What were the key findings regarding immune infiltration in osteoarthritis?

Immune infiltration analysis showed decreased infiltration of plasma cells, resting CD4 memory T cells, resting NK cells, monocytes, M2 macrophages, eosinophils, and neutrophils, while follicular helper T cells, gamma delta T cells, activated NK cells, M1 macrophages, and resting dendritic cells were increased in osteoarthritic cartilage.

Which genes were identified as potential diagnostic markers?

Six key genes were identified: ubiquitin-conjugating enzyme E2I (UBE2I), ribosomal protein S6 kinase 1 (RPS6KB1), interleukin-2 receptor beta chain (IL2RB), YEATS protein family member 4 (YEATS4), histone H4 variant (H4C8), and Toll-like receptor 3 (TLR3). Among these, TLR3 and IL2RB were highlighted as potential key genes.

How were the findings validated?

The findings were validated using an external dataset (GSE114007) and clinical samples from osteoarthritis patients and healthy controls, with RT-qPCR confirming the expression of the identified genes.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF